Remel Campy CVA Medium recalled for low Campylobacter recovery in culture
Remel's Campy CVA Medium (lot R01272, UDI 848838001055) is not reliably recovering Campylobacter Jejuni bacteria during laboratory culture testing. Customers reported low to no bacterial growth on this specific lot, which could lead to missed or delayed diagnoses.
From the FDA notice · Read the official notice ↗ · All Remel recalls
What to do
- Stop using lot R01272 (expires January 12, 2026) immediately
- Do not use UDI 848838001055 for any Campylobacter culture work
- Contact Remel or your supplier for replacement medium or instructions
- Review any culture results from this lot and consider retesting patient samples if clinically relevant
Is yours affected?
Compare your label or packaging with the recalled product.
- Product
- Campy CVA Medium 100/PK, R01272
- Sold in
- Nationwide
- Made for
- All ages (0 months and older)
Details
- Units affected
- 97
- Illnesses reported
- None reported
- Manufactured in
- 12076 Santa Fe Trail Dr, N/A, Lenexa, KS, United States
- Classification
- Class II
- Recall number
- Z-1474-2026
In the FDA's words
- Description
- Campy CVA Medium 100/PK, R01272 Customer complaints report low to no recovery of Campylobacter Jejuni ATCC 33291 on identified lot of medium. UDI-DI 848838001055 Lot R01272 lot 339135 Expired January 12, 2026 Distribution: US Nationwide distribution in the states of AZ, CO, IL, NJ, OH, TN, WA. Affected quantity: 97
- Hazard
- Customer complaints report low to no recovery of Campylobacter Jejuni ATCC 33291 on identified lot of medium.
More from Remel
See all- Remel Yeastone Broth recalled for possible false antifungal results
ModerateFDANov 3, 2026